This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.
Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.
Resolved shortages
The following shortages have been resolved and supply has resumed to the Irish market:
| Product | Active Ingredient(s) |
| Atorvastatin Teva 10mg Film Coated Tablets PA0749/110/001 Teva Pharma B.V. | Atorvastatin |
| Atorvastatin Teva 20mg Film Coated Tablets PA0749/110/002 Teva Pharma B.V. | Atorvastatin |
| Bendamustine HCl 100mg Powder for Concentrate for Solution for Infusion PA2059/028/002 Fresenius Kabi Deutschland GmbH | Bendamustine |
| Benylin Dual Action Dry Syrup PA0330/015/002 Johnson & Johnson (Ireland) Limited | Various |
| Buplex Rx 400mg Film Coated Tablets PA1986/117/002 Teva B.V. | Ibuprofen |
| Clavamel Forte 500mg/125mg Film Coated Tablet PA0126/243/001 Clonmel Healthcare Ltd | Amoxicillin & clavulanic acid |
Newly notified shortages
The HPRA has been notified of a shortage of the following products:
| Product | Active Ingredient(s) |
| Avamys Nasal Spray EU/1/07/434/001-003 GlaxoSmithKline (Ireland) Limited | Fluticasone |
| Budesonide Teva Pharma 1mg/2ml Nebuliser Suspension PA0749/207/003 Teva Pharma B.V. | Budesonide |
| Emazole 40mg Gastro Resistant Tablets PA0711/158/002 Rowex Ltd | Esomeprazole |
| Eplerenone Rowex 25mg Film Coated Tablets PA0711/235/001 Rowex Ltd | Eplerenone |
| Esomeprazole 40mg Gastro Resistant Tablets PA2315/127/004 Accord Healthcare Ireland Ltd. | Esomeprazole |
| Etoricoxib 90mg Film Coated Tablets PA0711/232/003 Rowex Ltd | Etoricoxib |
| Ezetimibe Teva 10mg Tablets PA1986/012/001 Teva B.V. | Ezetimibe |
| Fentanyl 100 micrograms in 2ml Solution for Injection PA0073/122/001 Mercury Pharmaceuticals (Ireland) Ltd | Fentanyl |
| Fental Matrix 25 micrograms/hour Transdermal Patch PA0711/146/001 Rowex Ltd | Fentanyl |
| Floxapen 500mg Powder for Solution for Injection or Infusion PA1986/111/002 Teva B.V. | Flucloxacillin |
| Montelukast Teva 5mg Chewable Tablets PA0749/048/002 Teva Pharma B.V. | Montelukast |
| Nasobec 50mcg Aqueous Nasal Spray PA1986/055/001 Teva B.V. | Beclometasone |
| Nasofan Aqueous 50mcg Nasal Spray Suspension PA1986/084/001 Teva B.V. | Fluticasone |
| Neurostil 400mg Capsules PA0749/164/003 Teva Pharma B.V. | Gabapentin |
| Novorapid 100 units/ml Solution for Injection Vial presentation only EU/1/99/119/001 Novo Nordisk A/S | Insulin aspart |
| One-Alpha 1mcg Soft Capsules PA2239/017/001 CHEPLAPHARM Arzneimittel GmbH | Alfacalcidol |
| Pendrex Plus 4mg/1.25mg Tablets PA0711/171/001 Rowex Ltd | Perindopril & indapamide |
| Procoralan 7.5mg Film Coated Tablets EU/1/05/316/8-14 Les Laboratoires Servier | Ivabradine |
| Questran 4g/Sachet, Powder for Oral Suspension PA2239/005/001 CHEPLAPHARM Arzneimittel GmbH | Colestyramine |
| Serc 8mg Tablets PA2010/016/001 Mylan IRE Healthcare Limited | Betahistine |
| Targin 20mg/10mg Prolonged-Release Tablets PA1688/010/003 Mundipharma Pharmaceuticals Limited | Oxycodone & naloxone |
| Tavanic 500mg Film Coated Tablets PA0540/077/003 Sanofi-Aventis Ireland Limited T/A SANOFI | Levofloxacin |
| Tyvense 20mg Hard Capsules PA23211/005/001 Takeda Pharmaceuticals International AG Ireland Branch | Lisdexamfetamine |
| Vertigon 8mg Tablets PA1445/023/001 Aurobindo Pharma (Malta) Limited | Betahistine |
| Xenical 120mg Hard Capsules EU/1/98/071/001 Cheplapharm Arzneimittel GmbH | Orlistat |
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA